Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
3 drugs for “Atypical Hemolytic Uremic Syndrome”
Approved 2
- IptacopanNOVARTIS AGAtypical Hemolytic Uremic Syndrome
- NarsoplimabOMEROS CORPAtypical Hemolytic Uremic Syndrome
Phase 3 1
- IptcaopanNOVARTIS AGAtypical Hemolytic Uremic Syndrome
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.